Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001182769-04-000002
Filing Date
2004-09-24
Accepted
2004-09-24 12:25:10
Documents
1
Period of Report
2004-08-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3077
  Complete submission text file 0001182769-04-000002.txt   5253
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ACCESS PHARMACEUTICALS INC 2600 STEMMONS FRWY STE 176 DALLAS TX 752072107
Business Address C/O ACCESS PHARMACEUTICALS INC 2600 STEMMONS FRWY STE 176 DALLAS TX 752072107 2149055100
NOWOTNIK DAVID P (Reporting) CIK: 0001182769 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 041044272